NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.82+0.03 (+3.89%)
Close on Nov 17, 2026Market cap $94.88MP/E –Yield –
NovaBridge Biosciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
NovaBridge Biosciences's total debt was CN¥29.97M at Dec 31, 2023. For fiscal 2023 it was CN¥29.97M, up 58.1% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | CN¥29.97M | +58.1% |
| FY2022 | Dec 31, 2022 | CN¥18.96M | -62.1% |
| FY2019 | Dec 31, 2019 | CN¥50.00M | -37.5% |
| FY2018 | Dec 31, 2018 | CN¥80.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | CN¥29.97M | – |
| Q4 FY2022 | Dec 31, 2022 | CN¥18.96M | – |
| Q4 FY2019 | Dec 31, 2019 | CN¥50.00M | – |
| Q4 FY2018 | Dec 31, 2018 | CN¥80.00M | – |
See a number that looks wrong?